Clinical Research Directory
Browse clinical research sites, groups, and studies.
Chinese Hemoptysis Registry Study (CHORE)
Sponsor: Qiu Jipeng
Summary
This is a prospective, multicenter, observational registry study of hemoptysis in China. Hospitalized patients with active hemoptysis who undergo vascular interventional diagnosis and therapy will be consecutively enrolled from tertiary hospitals across China. Baseline clinical, imaging, angiographic, procedural, and in-hospital outcome data will be collected, and patients will be followed at 1 and 3 months and every 6 months for at least 2 years. The study aims to describe the real-world epidemiology and etiology spectrum of hemoptysis in China, evaluate short- and long-term outcomes of interventional therapy, identify independent risk factors for recurrence, and build a recurrence prediction model to support standardized diagnosis and treatment of hemoptysis.
Official title: A Prospective, Multicenter, Observational Registry Study of the Etiology Spectrum, Interventional Management, and Long-term Outcomes of Hemoptysis in China
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
2500
Start Date
2026-10-10
Completion Date
2030-12-31
Last Updated
2026-10-15
Healthy Volunteers
Yes
Conditions
Interventions
Not applicable. This is an observational patient registry. All clinical procedures (including bronchial artery embolization) are part of routine medical care and are not assigned as study intervention
Not applicable. This is an observational patient registry. All clinical procedures (including bronchial artery embolization) are part of routine medical care and are not assigned as study interventions by the investigator.